1. Home
  2. TIVC vs QLGN Comparison

TIVC vs QLGN Comparison

Compare TIVC & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIVC
  • QLGN
  • Stock Information
  • Founded
  • TIVC 2016
  • QLGN 1996
  • Country
  • TIVC United States
  • QLGN United States
  • Employees
  • TIVC N/A
  • QLGN N/A
  • Industry
  • TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • QLGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • TIVC Health Care
  • QLGN Health Care
  • Exchange
  • TIVC Nasdaq
  • QLGN Nasdaq
  • Market Cap
  • TIVC 2.3M
  • QLGN 2.4M
  • IPO Year
  • TIVC 2021
  • QLGN N/A
  • Fundamental
  • Price
  • TIVC $0.46
  • QLGN $3.55
  • Analyst Decision
  • TIVC
  • QLGN
  • Analyst Count
  • TIVC 0
  • QLGN 0
  • Target Price
  • TIVC N/A
  • QLGN N/A
  • AVG Volume (30 Days)
  • TIVC 29.8M
  • QLGN 110.9K
  • Earning Date
  • TIVC 03-24-2025
  • QLGN 04-07-2025
  • Dividend Yield
  • TIVC N/A
  • QLGN N/A
  • EPS Growth
  • TIVC N/A
  • QLGN N/A
  • EPS
  • TIVC N/A
  • QLGN N/A
  • Revenue
  • TIVC $957,000.00
  • QLGN N/A
  • Revenue This Year
  • TIVC $324.15
  • QLGN N/A
  • Revenue Next Year
  • TIVC N/A
  • QLGN N/A
  • P/E Ratio
  • TIVC N/A
  • QLGN N/A
  • Revenue Growth
  • TIVC N/A
  • QLGN N/A
  • 52 Week Low
  • TIVC $0.20
  • QLGN $2.96
  • 52 Week High
  • TIVC $2.24
  • QLGN $29.45
  • Technical
  • Relative Strength Index (RSI)
  • TIVC 56.23
  • QLGN 47.06
  • Support Level
  • TIVC $0.45
  • QLGN $3.16
  • Resistance Level
  • TIVC $0.92
  • QLGN $3.75
  • Average True Range (ATR)
  • TIVC 0.09
  • QLGN 0.21
  • MACD
  • TIVC 0.02
  • QLGN 0.06
  • Stochastic Oscillator
  • TIVC 33.25
  • QLGN 67.25

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

Share on Social Networks: